SAN FRANCISCO--(BUSINESS WIRE)--McKesson Alternate Site Pharmacy℠ announced the launch of the PATH Pro™ Post-Acute Therapeutics Formulary Management Program for long-term care (LTC) pharmacies. PATH Pro™ offers easily accessible, third-party-reviewed clinical information that designates which of the most commonly dispensed generic drugs in the LTC setting are preferred and non-preferred for geriatric patients to help reduce drug-related hospital readmissions and minimize adverse events, reactio
For more information, please visit
http://www.businesswire.com/news/home/20[...]t-Acute-Therapeutics-Formulary